Intrinsic N-Terminal Reactivity and Improved Analysis of DSSO-Carbamate and Carbamate-Based Cross-Linkers
Cross-linking mass spectrometry (XL-MS) has emerged as a powerful approach for probing protein structure and conformational dynamics. Conventional cross-linkers typically contain two <i>N</i>-hydroxysuccinimide (NHS) ester groups that primarily target lysine residues. Here, we report the optimization of the in-solution reactivity of disuccinimidyl sulfoxide carbamate (DSSO-carbamate), an analogue of DSSO in which the two NHS ester groups are replaced by NHS carbamates. The enhanced stability of the carbamate functionality reduces the degradation of DSSO through retro-ene sulfoxide elimination under standard XL-MS buffer conditions, thereby improving cross-linking efficiency. We further characterized the gas-phase dissociation behavior of DSSO-carbamate and optimized the collision energy (CE) parameters for automated data analysis with XL-MS search engines. Mapping of cross-linking sites for bovine serum albumin revealed an unexpectedly high frequency of cross-links involving the protein N-terminus, suggesting increased N-terminal reactivity of NHS carbamates relative to NHS esters. This hypothesis was corroborated by comparative cross-linking of nonacetylated and N-terminally acetylated α-synuclein using DSSO-carbamate and the NHS ester-based disuccinimidyl dibutyric urea (DSBU). We observed the same reactivity trend for the NHS carbamate-based cross-linker NNP9. Proteome-wide XL-MS analysis confirmed a higher propensity of NHS carbamate-based reagents to form cross-links with protein N-termini compared to NHS ester-based cross-linkers. Together, these results show that NHS carbamate-based reagents provide complementary XL-MS restraints to NHS ester-based cross-linkers and are particularly useful for investigating systems where N-terminal interactions are functionally relevant. We anticipate that this unique N-terminal selectivity of NHS carbamates will find broader applications in bioconjugation and chemical proteomics.
Authors
- Iakovos Saridakis (ORCID: https://orcid.org/0000-0002-2690-5401)
- Claudio Iacobucci (ORCID: https://orcid.org/0000-0001-9592-3606)
- Christian Ihling (ORCID: https://orcid.org/0000-0003-2419-4391)
- Saad Shaaban (ORCID: https://orcid.org/0000-0002-2578-6260)
- Andrea Sinz (ORCID: https://orcid.org/0000-0003-1521-4899)
- Nuno Maulide (ORCID: https://orcid.org/0000-0003-3643-0718)
- Alessio Di Ianni
- Hendrik Krolle
- Bogdan-Razvan Brutiu
- Thomas Fabian Leischner
- Andrea Di Ianni
Institutions
- University of Vienna (AT)
- Merck KGaA, Darmstadt (Germany) (DE)
- University of L'Aquila (IT)
- Biotechnology Research Center (IR)
- Human Technopole (IT)
- Vision Technology (United States) (US)
- Institute of Molecular Biology and Biotechnology (BG)
- University of Turin (IT)
- Martin Luther University Halle-Wittenberg (DE)
- Merck Serono S.p.A. (Italy) (IT)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Analytical Chemistry
- Published
- 2026-03-11
- DOI
- https://doi.org/10.1021/acs.analchem.5c06834
- Primary Topic
- Mass Spectrometry Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00